Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease

Scandinavian Journal of Immunology

Volumn 75, Issue 1, 2012, Pages 109-114

  Kristan, S S ^a   Marc, M M ^a   Kern, I ^a   Flezar, M ^a   Suskovic, S ^a   Kosnik, M ^a   Korosec, P ^a  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; FIBROBLAST GROWTH FACTOR 2; GLUCOCORTICOID; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; AIRWAY REMODELING; ANGIOGENESIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; SMOKING; SPUTUM ANALYSIS; SPUTUM CYTODIAGNOSIS;

ADULT; AGED; FEMALE; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-8; LUNG; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RIBONUCLEASE, PANCREATIC; SPUTUM; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 83455260199     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02623.x     Document Type: Article

References (32)

1. Walters EH, Reid D, Soltani A, Ward C. Angiogenesis: a potentially critical part of remodelling in chronic airway diseases? Pharmacol Ther 2008;118:128-37.
2. Kasahara Y, Tuder RM, Taraseviciene-Stewart L et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-9.
3. Kanazawa H, Asai K, Hirata K et al. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 2003;114:354-8.
4. Papaioannou AI, Kostikas K, Kollia P, Gourgoulianis KI. Clinical implications for vascular endothelial growth factor in the lung: a friend or foe? Respir Res 2006;7:128.
5. Ferrara N. VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 2000;11:617-24.
6. Mura M, dos Santos CC, Stewart D, Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol 2004;97:1605-17.
7. Kazi AS, Lotfi S, Goncharova EA et al. Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. Am J Physiol Lung Cell Mol Physiol 2004;286:L539-45.
8. Kaner RJ, Crystal RG. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med 2001;7:240-6.
9. Kanazawa H, Asai K, Hirata K, Yoshikawa J. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 2003;114:354-8.
10. Kranenburg AR, de Boer WI, Alagappan VKT, Sterk PJ, Sharma HS. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax 2005;60:106-13.
11. Rovina N, Papapetropoulos A, Kollintza A et al. Vascular endothelial growth factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease? Respir Res 2007;8:53.
12. Fett JW, Strydom DJ, Lobb RR et al. Isolation and characterisation of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985;24:5480-6.
13. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995;6:230-47.
14. Kishimoto K, Liu S, Tsui T, Olson KA, Hu GF. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005;24:445-56.
15. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-67.
16. Mazzarella G, Grella E, D'Aduria D et al. Phenotypic features of alveolar monocytes/macrophages and IL-8 gene activation by IL-1 and TNF-a in asthmatic patients. Allergy 2000;55 (Suppl.):36-41.
17. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160:1532-9.
18. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma. Am J Respir Crit Care Med 2000;161:1185-90.
19. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family proteins. Annu Rev Biochem 1989;58:575-606.
20. Marc MM, Kristan SS, Rozman A et al. Complement factor C5a in acute exacerbation of chronic obstructive pulmonary disease. Scand J Immunol 2010;71:386-91.
21. Cataldo D, Foidart JM, Lau L, Bartsch P et al. Induced sputum: comparison between isotonic and hypertonic saline solution inhalation in patients with asthma. Chest 2001;120:1815-21.
22. Pizzichini E, Pizzichini M, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices in sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 1996;9:1174-80.
23. Valipour A et al. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clin Sci (Lond) 2008;115:225-32.
24. Simcock DE, Kanabar V, Clarke GW, O'Connor BJ, Lee TH, Hirst SJ. Pro-angiogenic activity in bronchoalveolar lavage fluid from asthmatics. Am J Respir Crit Care Med 2007;176:146-53.
25. Knox AJ, Stocks J, Sutcliffe A. Angiogenesis and vascular endothelial growth factor in COPD. Thorax 2005;60:88-9.
26. Aaron SD, Angel JB, Lunau M et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:349-55.
27. Sethi S, Muscarella K, Evans N et al. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000;118:1557-65.
28. Papi A, Bellettato CM, Braccioni F et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-21.
29. Saetta M, Di Stefano A, Maestrelli P et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994;150:1646-52.
30. Maestrelli P, Saetta M, Di Stefano A et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995;152:1926-31.
31. Zhu J, Qiu YS, Majumdar S et al. Exacerbations of bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med 2001;164:109-16.
32. Wright JL, Tai H, Churg A. Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries. Am J Respir Cell Mol Biol 2004;31:501-9.